UNITED  STATES
                   SECURITIES  AND  EXCHANGE  COMMISSION
                          WASHINGTON,  DC  20549

                              Form  10-QSB

     (Mark  One)
(X)  QUARTERLY  REPORT  PURSUANT  TO  SECTION  13  OR  15  (d)
     OF  THE  SECURTIES  EXCHANGE  ACT  OF  1934

For  the  quarterly  period  ended  September  30,  2003
                                    --------------------

( )  TRANSITION  REPORT  PURSUANT  TO  SECTION  13  OR  15  (d)
     OF  THE  SECURITIES  EXCHANGE  ACT  OF  1934

For  the  transition  period  from                   to
                                    ---------------      ----------------
                        COMMISSION FILE NUMBER 000-30711
                        --------------------------------

                            SECURITY BIOMETRICS, INC.
    -----------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

           Nevada                                            98-0209119
--------------------------------                    ----------------------------
 State  or other  jurisdiction                      (IRS Employer Identification
of incorporation or organization                                No.)


  1410 - 1030 West Georgia Street Vancouver, British Columbia, Canada, V6E 2Y3
  ----------------------------------------------------------------------------
                    (Address of principal executive offices)

Issuer's  telephone  number:  (604)  685-7749
                              ---------------

State the number of shares outstanding of each of the issuer's classes of common
stock  as  of  September  30,  2003

Common  Stock,  $.001  par  value                      136,160,007
---------------------------------                  ------------------
             Class                                 Number  of  shares


<PAGE>

                        SECURITY  BIOMETRICS,  INC.

                                 INDEX
                                 -----


PART  I

Item  1
Financial  Information                                      Page  No.
-----------------------------------------------------      -----------

Consolidated  Balance  Sheet  September  30,  2003. . . . . . .3-4

Consolidated  Statement  of  Comprehensive  Loss  for
 the three month periods ended September 2003 & 2002. . . . . .  5

Consolidated Statement of Operations for the three
 months  ended  September  2003  &  2002. . . . . . . . . . . .  6

Consolidated  Statement  of  Shareholders'  Equity
 for  the  three  ended  September  30,  2003 . . . . . . . . .  7

Consolidated  Statement  of  Cash  Flows  for  the
 three  months  ended  September,  30  2003  &  2002. . . . . .8-9

Notes to Consolidated Financial Statements for the
 period  ended  September  30,  2003. . . . . . . . . . . . .10-20

Item  2.
Management Discussion and Analysis of Results of
 Operations  and  Financial  Condition. . . . . . . . . . . .21-25

Item  3.
Controls  and  Procedures.

Signatures. . . . . . . . . . . . . . . . . . . . . . . . . .26-27


                                        2
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  BALANCE  SHEET

<TABLE>
<CAPTION>
                                                                  SEPTEMBER 30,     JUNE 30,
                                                                      2003            2003
                                                                   (Unaudited)      (Audited)
<S>                                                              <C>              <C>
CURRENT ASSETS
Cash and cash equivalents. . . . . . . . . . . . . . . . . . .   $      152,347   $      4,092
Accounts receivable. . . . . . . . . . . . . . . . . . . . . .          172,460         94,634
Inventory. . . . . . . . . . . . . . . . . . . . . . . . . . .            8,366              -
Prepaid expenses and other assets. . . . . . . . . . . . . . .           77,038         19,064
Current assets of discontinued operations. . . . . . . . . . .                -        137,270
                                                                 ---------------  -------------
                                                                        410,211        255,060
PROPERTY AND EQUIPMENT, NET OF ACCUMULATED
 DEPRECIATION. . . . . . . . . . . . . . . . . . . . . . . . .           64,619         65,018

LONG-TERM ASSETS OF DISCONTINUED OPERATIONS. . . . . . . . . .                -         23,783
                                                                 ---------------  -------------
                                                                 $      474,830   $    343,861
                                                                 ===============  =============
</TABLE>


                                        3
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  BALANCE  SHEET  (CONTINUED)

<TABLE>
<CAPTION>
                                                                  SEPTEMBER 30,     JUNE 30,
                                                                      2003            2003
                                                                   (Unaudited)      (Audited)
<S>                                                              <C>              <C>
CURRENT LIABILITIES
Accounts payable and accrued liabilities - non-related parties.  $      974,610   $    686,762
Accounts payable and accrued liabilities - related parties. . .       1,532,041      1,540,704
Corporate income taxes payable. . . . . . . . . . . . . . . . .         424,542        424,542
Capital lease payable . . . . . . . . . . . . . . . . . . . . .           4,794          5,230
Notes payable . . . . . . . . . . . . . . . . . . . . . . . . .       2,000,000      2,000,000
Convertible debentures. . . . . . . . . . . . . . . . . . . . .       1,680,000      1,780,000
Current liabilities of discontinued operations. . . . . . . . .               -        719,955
                                                                 ---------------  -------------
TOTAL CURRENT LIABILITIES . . . . . . . . . . . . . . . . . . .       6,615,987      7,157,193
                                                                 ---------------  -------------


LONG-TERM LIABILITIES
  Capital lease - long term portion . . . . . . . . . . . . . .               -            872
  Minority interest in equity of consolidated subsidiary. . . .             121            193
                                                                 ---------------  -------------
TOTAL LONG-TERM LIABILITIES . . . . . . . . . . . . . . . . . .             121          1,065
                                                                 ---------------  -------------


STOCKHOLDERS' DEFICIENCY
COMMON STOCK
  Authorized - 300,000,000 shares $0.001 par value
  Issued and outstanding 136,160,007 shares . . . . . . . . . .         136,160        124,296
  Additional paid-in capital. . . . . . . . . . . . . . . . . .       9,185,046      8,201,508
  Accumulated other comprehensive loss. . . . . . . . . . . . .          (6,453)        (5,247)
  Accumulated deficit . . . . . . . . . . . . . . . . . . . . .     (15,456,031)   (15,134,954)
                                                                 ---------------  -------------
TOTAL STOCKHOLDERS' DEFICIENCY. . . . . . . . . . . . . . . . .      (6,141,278)    (6,814,397)
                                                                 ---------------  -------------
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY. . . . . . . . .  $      474,830   $    343,861
                                                                 ===============  =============
</TABLE>

See  Accompanying  Notes


                                        4
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  COMPREHENSIVE  LOSS
(UNAUDITED)

<TABLE>
<CAPTION>

                                          THREE MONTHS     THREE MONTHS
                                              ENDED            ENDED
                                          SEPTEMBER 30,    SEPTEMBER 30,
                                              2003             2002
                                         ---------------  --------------
<S>                                      <C>              <C>
NET LOSS. . . . . . . . . . . . . . . .  $     (321,077)  $     (185,802)
OTHER COMPREHENSIVE LOSS
Foreign currency translation adjustment          (1,206)            (820)
                                         ---------------  --------------
COMPREHENSIVE LOSS. . . . . . . . . . .  $     (322,283)  $     (184,982)
                                         ===============  ===============

</TABLE>

See  Accompanying  Notes


                                        5
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  OPERATIONS
(UNAUDITED)

<TABLE>
<CAPTION>
                                                      THREE MONTHS     THREE MONTHS
                                                          ENDED            ENDED
                                                      SEPTEMBER 30,    SEPTEMBER 30,
                                                          2003             2002
                                                     ---------------  ---------------
<S>                                                  <C>              <C>
REVENUE
Contract revenues earned. . . . . . . . . . . . . .  $      158,700   $      667,534
Other revenues. . . . . . . . . . . . . . . . . . .          12,067           10,000
                                                     ---------------  ---------------
TOTAL REVENUE . . . . . . . . . . . . . . . . . . .         170,767          677,534
                                                     ---------------  ---------------

COSTS AND EXPENSES
Cost of revenues earned . . . . . . . . . . . . . .          77,111          200,962
Interest expense. . . . . . . . . . . . . . . . . .          90,189           95,295
Selling, general and administrative . . . . . . . .         684,477          487,755
                                                     ---------------  ---------------
TOTAL COSTS AND EXPENSES. . . . . . . . . . . . . .         851,777          784,012
                                                     ---------------  ---------------
LOSS FROM CONTINUING OPERATIONS . . . . . . . . . .        (681,010)        (106,478)

OTHER ITEM
Income (loss) from discontinued operations. . . . .         359,933          (79,324)
                                                     ---------------  ---------------
NET LOSS. . . . . . . . . . . . . . . . . . . . . .  $     (321,077)  $     (185,802)
                                                     ===============  ===============

NET LOSS PER COMMON SHARE
Basic and diluted . . . . . . . . . . . . . . . . .  $        (0.00)  $        (0.00)
                                                     ===============  ===============

WEIGHTED AVERAGE NUMBER OF COMMON STOCK OUTSTANDING
Basic and diluted . . . . . . . . . . . . . . . . .     124,995,093      118,853,383
                                                     ===============  ===============

</TABLE>

See  Accompanying  Notes


                                        6
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  STOCKHOLDERS'  EQUITY
(UNAUDITED)

<TABLE>
<CAPTION>
                                                                          ACCUMULATED
                                   COMMON STOCK           ADDITIONAL         OTHER
                           ---------------------------      PAID IN      COMPREHENSIVE    ACCUMULATED
                              SHARES         AMOUNT         CAPITAL          LOSS          DEFICIT         TOTAL
                           -------------  ------------  ---------------  -------------  -------------  -------------
<S>                        <C>            <C>           <C>              <C>            <C>            <C>
BALANCE, JUNE 30, 2003. .   124,296,257   $    124,296  $    8,201,508   $     (5,247)  $(15,134,954)  $ (6,814,397)
ISSUANCE OF COMMON
 STOCK FOR:
Cash (net of $36,401
 finders' fees paid). . .    10,263,750         10,264         809,485              -              -        819,749
Issuance of shares for
 services . . . . . . . .       500,000            500          74,500              -              -         75,000
Issuance of shares to
 settle debt. . . . . . .     1,100,000          1,100          98,900              -              -        100,000
Issuance of common stock
 by subsidiary. . . . . .             -              -             653              -              -            653
OTHER COMPREHENSIVE
 LOSS FOR  THE THREE
 MONTHS PERIOD ENDED
 SEPTEMBER 30,  2003. . .                                                      (1,206)             -         (1,206)
NET LOSS FOR THE THREE
 MONTHS PERIOD ENDED
 SEPTEMBER 30, 2003 . . .             -              -               -              -       (321,077)      (321,077)
                           -------------  ------------  ---------------  -------------  -------------  -------------
BALANCE, SEPTEMBER 30,
2003. . . . . . . . . . .   136,160,007   $    136,160  $    9,185,046   $     (6,453)  $(15,456,031)  $ (6,141,278)
                           =============  ============  ===============  =============  =============  =============
</TABLE>

See  Accompanying  Notes


                                        7
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  CASH  FLOWS
(UNAUDITED)

<TABLE>
<CAPTION>
                                                                   THREE MONTHS     THREE MONTHS
                                                                       ENDED            ENDED
                                                                   SEPTEMBER 30,    SEPTEMBER 30,
                                                                       2003             2002
                                                                  ---------------  --------------
<S>                                                               <C>              <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss from continuing operations. . . . . . . . . . . . . . .  $     (681,010)  $     (106,478)
Adjustments to reconcile net loss to net cash provided (used) by
 operating activities
Depreciation . . . . . . . . . . . . . . . . . . . . . . . . . .           2,487           14,547
Consulting services. . . . . . . . . . . . . . . . . . . . . . .          12,500          102,800
Changes in operating assets and liabilities:
Accounts receivable. . . . . . . . . . . . . . . . . . . . . . .         (77,826)         (49,408)
Inventory. . . . . . . . . . . . . . . . . . . . . . . . . . . .          (8,366)         (10,927)
Prepaid expenses . . . . . . . . . . . . . . . . . . . . . . . .           4,526           16,455
Accounts payable and accrued liabilities . . . . . . . . . . . .         279,185           36,723
Corporation income taxes payable . . . . . . . . . . . . . . . .               -            4,929
Costs and estimated profits in excess of billings on . . . . . .               -          (31,537)
 uncompleted contracts
Billings in excess of costs and estimated earnings on. . . . . .               -         (541,245)
 uncompleted contracts
                                                                  ---------------  ---------------
NET CASH USED BY OPERATING ACTIVITIES. . . . . . . . . . . . . .        (468,504)        (564,141)
                                                                  ---------------  ---------------

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment . . . . . . . . . . . . . . .          (2,087)          (2,623)
Advances to subsidiary - discontinued operations . . . . . . . .        (198,969)        (153,146)
                                                                  ---------------  ---------------
NET CASH USED BY INVESTING ACTIVITIES. . . . . . . . . . . . . .  $     (201,056)  $     (155,769)
                                                                  ---------------  ---------------
</TABLE>

See  Accompanying  Notes


                                        8
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
CONSOLIDATED  STATEMENT  OF  CASH  FLOWS  (CONTINUED)
(UNAUDITED)

<TABLE>
<CAPTION>
                                                                   THREE MONTHS     THREE MONTHS
                                                                       ENDED            ENDED
                                                                   SEPTEMBER 30,    SEPTEMBER 30,
                                                                       2003             2002
                                                                  ---------------  --------------
<S>                                                               <C>              <C>
CASH FLOWS FROM FINANCING ACTIVITIES:
Increase in bank overdraft. . . . . . . . . . . . . . . . . . .   $            -   $       70,983
Net proceeds from common stock. . . . . . . . . . . . . . . . .          820,329          203,611
Payments on capital lease . . . . . . . . . . . . . . . . . . .           (1,308)            (457)
Payments of equipment note. . . . . . . . . . . . . . . . . . .                -           (5,103)
                                                                  ---------------  ---------------
NET CASH PROVIDED BY FINANCING ACTIVITIES . . . . . . . . . . .          819,021          269,034
                                                                  ---------------  ---------------

EFFECT ON EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS. .           (1,206)             820
                                                                  ---------------  ---------------


NET INCREASE (DECREASE) IN CASH AND CASH. . . . . . . . . . . .          148,255         (450,056)
 EQUIVALENTS FROM CONTINUING OPERATIONS

DECREASE IN CASH FROM DISCONTINUED OPERATIONS . . . . . . . . .                -           (1,431)
 - NOTE 3

CASH AND CASH EQUIVALENTS, AT BEGINNING OF PERIOD . . . . . . .            4,092          483,275
                                                                  ---------------  ---------------
CASH AND CASH EQUIVALENTS, AT END OF PERIOD . . . . . . . . . .   $      152,347   $       31,788
                                                                  ===============  ===============

SUPPLEMENTAL DISCLOSURE OF CASH FLOW
 INFORMATION
CASH PAID DURING PERIOD FOR:
Interest. . . . . . . . . . . . . . . . . . . . . . . . . . . .   $            -   $       95,517
                                                                  ===============  ===============
Taxes . . . . . . . . . . . . . . . . . . . . . . . . . . . . .   $            -   $            -
                                                                  ===============  ===============

NON-CASH INVESTING AND FINANCIAL ACTIVITIES

ISSUANCE OF COMMON STOCK FOR:
Prepaid expense . . . . . . . . . . . . . . . . . . . . . . . .   $       62,500   $            -
                                                                  ===============  ===============
Services. . . . . . . . . . . . . . . . . . . . . . . . . . . .   $       12,500   $      102,800
                                                                  ===============  ===============
Settle convertible debentures . . . . . . . . . . . . . . . . .   $      100,000   $            -
                                                                  ===============  ===============

</TABLE>

See  Accompanying  Notes


                                        9
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES

ORGANIZATION  AND  NATURE  OF  BUSINESS
---------------------------------------
SECURITY  BIOMETRICS,  INC.  AND  BIOMETRICS  SECURITY,  INC.
Security Biometrics, Inc. (hereinafter referred to as "the Company") is a Nevada
corporation  incorporated  on  March  12,  1999.

On August 25, 2000, the Company acquired all of the issued and outstanding stock
of  Biometrics Security, Inc. (hereinafter referred to as "BSI") in exchange for
38,257,675  shares  of  the  Company's common stock. (37,500,000 of these shares
were  owned by a trust whose beneficiaries were the children of a former officer
of  the  Company).  This transaction has the effect of what is commonly referred
to  as  a  "reverse  acquisition"  in  that  the  Company is the legal acquirer;
however,  BSI is the accounting acquirer.   In connection with the legal form of
this  transaction,  BSI  became  a  wholly-owned subsidiary of the Company.  For
accounting  purposes,  the  acquisition  is treated as a recapitalization of BSI
rather  than  a  business  combination.

The  Company  is a holding company for subsidiary acquisitions.  The Company and
its subsidiaries intend to develop, market under license, and distribute dynamic
biometric  technologies.

BASIS  OF  PRESENTATION
The  unaudited  financial statements of the Company as at September 30, 2003 and
2002,  and  for  the  three  months  ended September 30, 2003 and 2002 have been
prepared  in  accordance  with  accounting  principles generally accepted in the
United  States  for  interim reporting.  Accordingly, they do not include all of
the  disclosures  required  by  accounting  principles generally accepted in the
United  States  for  complete financial statements and notes thereto included in
the  Company's  Form 10-KSB for the year ended June 30, 2003.  In the opinion of
management,  all  adjustments  (consisting only of normal recurring adjustments)
considered  necessary  for  a  fair  presentation  of  the  interim  financial
information have been included. The results of operations for any interim period
are not necessarily indicative of the results of operations for the entire year.

GOING  CONCERN
The  Company  experienced  significant  operating  losses  since  inception.  In
addition,  as  at  September 30, 2003, the Company has a working capital deficit
amounting  to  approximately $6.2 million. The consolidated financial statements
have  been  prepared  assuming  the  Company will continue to operate as a going
concern  which  contemplates  the  realization  of  assets and the settlement of
liabilities  in  the  normal course of business.  No adjustment has been made to
the  recorded  amount  of  assets  or  the  recorded amount or classification of
liabilities  which  would be required if the Company were unable to continue its
operations.   Management  has  negotiated  a financial reorganization plan which
the  Company  believes  should  address  some  or  all  of its present financial
condition.

PRINCIPLES  OF  CONSOLIDATION
The  consolidated  financial  statements  include  the  accounts  of  Security
Biometrics,  Inc.  and  the  following  subsidiaries:

                    Biometrics  Security,  Inc.
                    Lightec  Communications  Corp.
                    Datadesk  Technologies,  Inc.  (disposed on August 20, 2003)
                    EMedRx,  Inc.
                    NetFace,  LLC  (Inactive)

All  material  inter-company  accounts  and  transactions  have been eliminated.


                                       10
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  (CONTINUED)

CASH  AND  CASH  EQUIVALENTS
----------------------------
For  purposes  of  the statement of cash flows, the Company considers all highly
liquid  debt  instruments purchased with an original maturity of three months or
less  to  be  cash  equivalents.

ACCOUNTING  ESTIMATES
---------------------
Management  uses  estimates  and assumptions in preparing consolidated financial
statements  in  accordance  with generally accepted accounting principles in the
United  States.  Those  estimates and assumptions affect the reported amounts of
assets and liabilities, the disclosure of contingent assets and liabilities, and
the  reported  revenues  and  expenses.  Actual  results  could  vary  from  the
estimates  that  were  used.  Significant  estimates  used  in  these  financial
statements include fair values and impairment analysis of the Company's Property
and  Equipment.

REVENUE  AND  COST  RECOGNITION
-------------------------------
LIGHTEC
-------
Lightec  recognizes  revenues  from  fixed-price  and  modified  fixed-price
construction  contracts  on the percentage-of-completion method, measured by the
percentage  of  cost incurred to date to estimated total cost for each contract.
This  method  is  used  because  management  considers total cost to be the best
available  measure  of  progress  on  the  contracts.  Because  of  inherent
uncertainties  in  estimating costs, it is at least reasonably possible that the
estimates  used  will  change  within  the  near  term.

Revenue from time-and-materials contracts is recognized currently as the work is
performed.

Contract  costs  include  all direct material and labor costs and those indirect
costs  related to contract performance, such as indirect labor, supplies, tools,
repairs,  and  depreciation.  Selling,  general  and  administrative  costs  are
charged  to expense as incurred.  Provisions for estimated losses on uncompleted
contracts  are  made in the period in which such losses are determined.  Changes
in  job  performance,  job conditions, and estimated profitability may result in
revisions  to  costs and income, which are recognized in the period in which the
revisions are determined.  Changes in estimated job profitability resulting from
job  performance,  job  conditions,  contract  penalty  provision, claims change
orders and settlements, are accounted for as changes in estimates in the current
period.

The  asset,  "Costs  and estimated earnings in excess of billings on uncompleted
contracts",  represents  revenues  recognized  in excess of amounts billed.  The
liability,  "Billings  in  excess of costs and estimated earnings on uncompleted
contracts",  represents  billings  in  excess  of  revenues  recognized.

Revenue  from  claims  is recognized when realization is probable and the amount
can  be reliably estimated.  When realization is probable, but the amount cannot
be  reliably  estimated,  revenue is recognized to the extent of costs incurred.

Datadesk
--------
Product  sales  -  when  goods  are  shipped  and  title passes to the customer.
Keyboard  development  fees  -  when  services  are  performed.
Royalties  -  when  the  licensee  sells the product and reports the sale to the
Company.

Accounts  Receivable
--------------------
Accounts receivable are reported at the customers' outstanding balances less any
allowance  for  doubtful  accounts, marketing credits and allowance for possible
sales  returns.


                                       11
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  (CONTINUED)

ALLOWANCE  FOR  DOUBTFUL  ACCOUNTS, MARKETING CREDITS AND ALLOWANCE FOR POSSIBLE
--------------------------------------------------------------------------------
SALES  RETURNS
--------------
The  allowance  for doubtful accounts is charged to income in amounts sufficient
to  maintain  the  allowance at a level management believes is adequate to cover
any  possible  losses,  credits  or  returns.

INVENTORY
---------
Datadesk's inventory is stated at the lower of cost (determined on the first-in,
first-out  method)  or  market.

PROPERTY  AND  EQUIPMENT
------------------------
Property  and Equipment are stated at cost.  Major renewals and improvements are
charged to the asset accounts while replacements, maintenance and repairs, which
do  not  improve or extend the lives of the respective assets, are expensed.  At
the  time property and equipment are retired or otherwise disposed of, the asset
and  related  accumulated  depreciation  accounts are relieved of the applicable
amounts.  Gains  or  losses from retirements or sales are credited or charged to
income.

The  Company  depreciates  its  property  and  equipment for financial reporting
purposes using the straight-line method based upon the following useful lives of
the  assets:

               Furniture  and  fixtures       7-10  Years
               Machinery  and  equipment      5  Years
               Computer  equipment            5  Years
               Vehicles                       5  Years

ACCOUNTING  FOR  CONVERTIBLE  DEBT  SECURITIES
----------------------------------------------
The  Company  has  issued  convertible  debt  securities  with  a non-detachable
conversion  feature  that were "in the money" at the date of issue.  The Company
accounts for such securities in accordance with Emerging Issues Task Force Topic
98-5.  The  Company  has  recorded  the  fair value of the beneficial conversion
feature  as  an  interest  expense  and  increase in Additional Paid-In Capital.

The  beneficial  interest  is computed by subtracting the stock conversion price
from  the  market  price  of  the  stock times the number of shares and warrants
eligible  for  conversion.

INCOME  TAXES
-------------
Provisions  for  income  taxes  are based on taxes payable or refundable for the
current  year  and deferred taxes on temporary differences between the amount of
taxable  income  and pretax financial income and between the tax basis of assets
and  liabilities  and  their  reported  amounts  in  the  financial  statements.
Deferred  tax assets and liabilities are included in the financial statements at
currently  enacted  income  tax  rates  applicable  to  the  period in which the
deferred  tax  assets  and liabilities are expected to be realized or settled as
prescribed in Statement of Financial Accounting Standards ("SFAS") SFAS No. 109,
Accounting  for  Income  Taxes.  As  changes  in  tax laws or rates are enacted,
deferred  tax  assets  and  liabilities  are  adjusted through the provision for
income  taxes.

NET  (LOSS)  PER  SHARE
-----------------------
The  Company  adopted SFAS No. 128 that requires the reporting of both basic and
diluted  (loss)  per  share.  Basic (loss) per share is computed by dividing net
(loss) available to common stockholders by the weighted average number of common
shares  outstanding  for  the  period.  Diluted  (loss)  per  share reflects the
potential  dilution  that  could occur if securities or other contracts to issue
common  stock  were exercised or converted into common stock. In accordance with
SFAS  No.  128,  any  anti-dilutive effect on net (loss) per share are excluded.


                                       12
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  1     SUMMARY  OF  SIGNIFICANT  ACCOUNTING  POLICIES  (CONTINUED)

LONG-LIVED  ASSETS
------------------
SFAS  No. 144, "Accounting for the Impairment or Disposal of Long-lived Assets,"
requires  that  long-lived  assets be reviewed for impairment whenever events or
changes  in  circumstances  indicate  that  the  carrying amount of the asset in
question may not be recoverable.  For the three month period ended September 30,
2003,  this  standard did not have a material effect on the Company's results of
operations,  cash  flows  or  financial  position.

DISCLOSURE  ABOUT  FAIR  VALUE  OF  FINANCIAL  INSTRUMENTS
----------------------------------------------------------
The  Company  estimates  that  the fair value of all financial instruments as of
September  30, 2003, as defined in SFAS No. 107, does not differ materially from
the  aggregate  carrying  values  of  its  financial instruments recorded in the
accompanying  balance  sheet.  The  estimated  fair  value  amounts  have  been
determined  by  the  Company  using available market information and appropriate
valuation  methodologies.  Considerable  judgment  is  required  in interpreting
market  data  to  develop  the  estimates  of  fair  value, and accordingly, the
estimates  are  not necessarily indicative of the amounts that the Company could
realize  in  a  current  market  exchange.

STOCK-BASED  COMPENSATION
-------------------------
The  Company  has  elected to account for stock-based compensation following APB
No.  25  "Account  for  Stock  Issued  to  Employees",  and  provides disclosure
requirements  under  SFAS  No. 123 "Accounting for Stock-based Compensation", as
amended  by  FASB  No. 148, Accounting for Stock-based Compensation - Transition
and  Disclosure,  an  amendment  of  SFAS  No.  123.

STOCK  ISSUED  BY  SUBSIDIARY
-----------------------------
The issuance of stock by a subsidiary to third parties reduces the proportionate
ownership  interest  in  the  investee.  The  subsidiary's  plan  is to continue
raising  funds through private placements and as a result, the additional equity
raised  has  been  included  in  additional  paid-in  capital.

COMPREHENSIVE  INCOME
---------------------
The  Company  has  adopted  SFAS  No.  130,  "Reporting  Comprehensive  Income".
Comprehensive  income  is comprised of foreign currency translation adjustments.

FOREIGN  CURRENCY  TRANSLATION
------------------------------
The  financial  statements  of  the Company are measured using the United States
dollar as the functional and reporting currency.  Assets, liabilities and equity
accounts  of  the  Company are translated from foreign currency to United States
currency  at  exchange  rates  as  of  the  balance  sheet  date  or  historical
acquisition date, depending on the nature of the account.  Revenues and expenses
are  translated  at  average  rates  of exchange in effect during the year.  The
resulting  cumulative  translation  adjustments have been recorded as a separate
component  of  stockholders'  equity.

SHIPPING  AND  HANDLING  COSTS
------------------------------
The  Company's policy is to classify shipping and handling costs as part of cost
of  goods  sold  in  the  statement  of  operations.


                                       13
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  2     DISPOSITION  OF  DISCONTINUED  OPERATIONS

During the three month period ended September 30, 2003, the Company entered into
a Stock and Note Transfer Agreement (the "Transfer Agreement") with Pan Pacifica
Ltd.  ("Pan  Pacifica"), effective as of August 20, 2003, to transfer all of the
outstanding  shares of Datadesk, a wholly-owned subsidiary of the Company, and a
promissory  note payable to the Company made by Datadesk in the principal amount
of  $1,000,000,  together  with  the  related security interest in the assets of
Datadesk  to  Pan  Pacifica.   The  Transfer  Agreement  was  entered  into
simultaneously  with  a  settlement agreement between the Company and its former
officer.  In  connection  with the settlement, the Company transferred available
funds  in  the  amount  of  $151,020  to  Pan  Pacifica.

The  Company  realized  a  net  gain  on  the disposal of Datadesk subsidiary of
$382,073  which was recognized at the date of disposition.  The realized gain is
net  of  approximately  $47,949  transaction  costs.

NOTE  3     STATEMENT  OF  CASH  FLOWS

Loss  from  discontinued  operations  is  as  follows:

<TABLE>
<CAPTION>
                                                                    2003        2002
                                                                 ----------  ----------
<S>                                                              <C>         <C>
Revenue . . . . . . . . . . . . . . . . . . . . . . . . . . . .  $   6,431   $ 177,901
Direct expenses . . . . . . . . . . . . . . . . . . . . . . . .          -      28,025
                                                                 ----------  ----------
                                                                     6,431     119,876
Gross profit

Administrative and General. . . . . . . . . . . . . . . . . . .    (28,571)   (198,978)
Interest expenses . . . . . . . . . . . . . . . . . . . . . . .          -        (222)
                                                                 ----------  ----------
Net operating loss. . . . . . . . . . . . . . . . . . . . . . .    (22,140)    (79,324)
Other item
Gain on disposition of subsidiary . . . . . . . . . . . . . . .    382,073           -
                                                                 ----------  ----------
Income (loss) from discontinued operations for the period . . .  $ 359,933   $ (79,324)
                                                                 ==========  ==========

Cash flows from discontinued operations are as follows:
                                                                    2003        2002
                                                                 ----------  ----------
Operating Activities
Net income (loss) for the period. . . . . . . . . . . . . . . .  $ 359,933   $ (79,324)
Items not involving cash:
Amortization of capital assets. . . . . . . . . . . . . . . . .          -       3,283
Gain on disposition of subsidiary . . . . . . . . . . . . . . .   (382,073)          -
Changes in non-cash working capital balances consist of:
Accounts receivable . . . . . . . . . . . . . . . . . . . . . .     (2,910)    (21,850)
Inventories . . . . . . . . . . . . . . . . . . . . . . . . . .      2,375       9,148
Accounts payable and accrued liabilities. . . . . . . . . . . .   (182,198)    (63,237)
                                                                 ----------  ----------
                                                                  (204,873)   (151,980)
                                                                 ----------  ----------
Investing Activity
Purchase of capital assets. . . . . . . . . . . . . . . . . . .          -      (2,597)
                                                                 ----------  ----------

Financing Activities
Bank indebtedness . . . . . . . . . . . . . . . . . . . . . . .      5,904           -
Due to related party. . . . . . . . . . . . . . . . . . . . . .    198,969     153,146
                                                                 ----------  ----------
                                                                   204,873     153,146
                                                                 ----------  ----------
Decrease in cash from discontinued operations during the period  $       -   $  (1,431)
                                                                 ==========  ==========
</TABLE>


                                       14
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  4     ACCOUNTS  RECEIVABLE

A  summary  of  accounts  and  other  receivable  is  as  follows:

<TABLE>
<CAPTION>
<S>                                                                               <C>

Account receivable . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  $173,942
Less: allowance for doubtful accounts, sales returns, and advertising incentives   (10,995)
                                                                                  ---------
                                                                                   162,947
Tax credits recoverable. . . . . . . . . . . . . . . . . . . . . . . . . . . . .     9,513
                                                                                  ---------

Total accounts receivable. . . . . . . . . . . . . . . . . . . . . . . . . . . .  $172,460
                                                                                  =========

NOTE 5     PROPERTY AND EQUIPMENT

Property and equipment and accumulated depreciation consists of:

Furniture and fixtures . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  $ 64,198
Computer equipment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .    18,114
                                                                                  ---------
                                                                                    82,312
Less accumulated depreciation. . . . . . . . . . . . . . . . . . . . . . . . . .   (17,693)
                                                                                  ---------
Total property and equipment . . . . . . . . . . . . . . . . . . . . . . . . . .  $ 64,619
                                                                                  =========
</TABLE>


NOTE  6     CAPITAL  LEASE  PAYABLE

The  Company  acquired an office copier on a capital lease with National Leasing
Group,  Inc.  The  lease  requires monthly payments of approximately $400 for 48
months  including  interest  at  11%  per annum.  Future minimum payments are as
follows:

June 30, 2004. . . . . . . . . . . . .  $ 5,230
June 30, 2005. . . . . . . . . . . . .      872
                                        --------

Total minimum lease payment. . . . . .    6,102
Less amount representing interest. . .   (1,308)
                                        --------
Present value of minimum lease payment  $ 4,794
                                        ========


                                       15
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  7     NOTES  PAYABLE
<TABLE>
<CAPTION>
                                                                                  SEPTEMBER 30,
                                                                                      2003
                                                                                  -------------
<S>                                                                               <C>
MARYANNE  RICHARD
On  June  13, 2002, the Company issued a note payable to Maryanne Richard in the
amount  of  $1,000,000 as part of the consideration for the purchase of Lightec.
The note bears interest at 9% and currently requires $250,000 principal payments
on  September  30, 2002, December 31, 2002 and a final $500,000 payment on March
31,  2003.  Included in accrued liabilities at September 30, 2003 is $116,877 of
accrued interest.  The note is secured by deposit accounts, investment property,
letters  of credit rights and letters of credit, rights to payments evidenced by
chattel  paper,  rights  to payments for money or funds advanced or sold and all
proceeds  of  any and all of the above.  The security is co-equal in priority to
the  security  granted  for  the  $1,000,000  note  payable  to  Synergex Group.
Consideration  of  8,000,000  stock purchase warrants, which gives the rights to
the  holder  to  acquire  one  share  of common stock at a price of $0.125 for a
period  of two years, was given to extend the repayment terms by three months to
commence  on  December  31,  2002.  The  granting  of stock purchase warrants is
subject  to Lightec obtaining funding on the Bridgeport contract. As of the date
of  this  statement,  the Company has defaulted the repayments starting December
31,  2002.  Interest  payments  on  the  loan  are  currently  in  arrears.

Pursuant  to  an agreement dated October 29, 2003, the Company has agreed to set
the principal of the note at $1,105,000 ("new principal").  Interest will accrue
on  the  new principal at the rate of 9% per annum commencing on the date of the
first  receipt  of  funds from the Bridgeport School contract.  Payments against
the  new principal and accrued interest will commence once the $281,500 included
in  accounts payable - related entities, has been repaid.  This $281,500 is owed
to  Mike  Richard  (a  former  director  of  Lightec)  pursuant to an employment
contract.  9%  of  the  receipts  from  the  Bridgeport  School contract will be
applied  against  these  debts.
                                                                                  $   1,000,000

SYNERGEX  GROUP  PARTNERSHIP
On  June  11,  2002, Synergex Group Partnership loaned the Company $1,000,000 to
facilitate  the  acquisition  of  Lightec.  The  note  bears  interest at 9% and
currently  requires  $250,000  principal payments on September 30, 2002, October
31,  2002,  November  30,  2002  and  December  31,  2002.  Included  in accrued
liabilities  at September 30, 2003 is $117,370 of accrued interest.  The note is
secured  by  deposit accounts, investment property, letters of credit rights and
letters  of  credit,  rights  to  payments evidenced by chattel paper, rights to
payments  for money or funds advanced or sold and all proceeds of any and all of
the above.  The security is co-equal in priority to the security granted for the
$1,000,000  note  payable to Mary Anne Richard. Consideration of 8,000,000 stock
purchase  warrants, which gives the rights to the holder to acquire one share of
common stock at a price of $0.125 for a period of two years, was given to extend
the  repayment  terms  by  three  months  to  commence on December 31, 2002. The
granting  of  share purchase warrants is subject to Lightec obtaining funding on
the  Bridgeport  contract.  As  of  the  date of this statement, the Company has
defaulted  the  repayments starting December 31, 2002.  Interest payments on the
loan  are  currently  in  arrears.
</TABLE>


                                       16
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  7     NOTES  PAYABLE  (CONTINUED)

<TABLE>
<CAPTION>
<S>                                                                               <C>

Pursuant  to  an  agreement dated September 12, 2003, the Company is required to
pay  the  following:

i)  pay  the  principal  plus  all interest accrued in the outstanding principal
balance  at  the  rate  of  9%  per  annum from the date of receipt of the first
payment  related  to  the  Bridgeport  School  contract  until  paid  in  full;

ii)  pay  no  less  than 7.4% of all money received on account of the Bridgeport
School  contract  until  paid  in  full.
                                                                                      1,000,000
                                                                                  -------------
                                                                                  $   2,000,000
                                                                                  =============

NOTE  8     CONVERTIBLE  DEBENTURE  PAYABLE

                                                                                  SEPTEMBER 30,
                                                                                      2003
                                                                                  -------------
EDINBURGH INVESTMENTS LLC
On  June  30,  2002,  the  Company  issued  a convertible debenture to Edinburgh
Investments  LLC ("Edinburgh").  The debenture is unsecured, matured on June 30,
2003 and accrues interest at 10% payable quarterly.  Edinburgh has the option to
convert  the  debenture into the Company's common stock at a conversion price of
$0.30  per  share,  subject  to  anti-dilution adjustments. Because the interest
payments  on the loan are currently in arrears and the Company has defaulted the
payment  on  June  30,  2003,  the  Company  has  breached  the  loan agreement.

On  August 29, 2003, Edinburgh obtained a court order for settlement against the
Company  requiring  the  Company  to  pay  the  following:

i)  pay  Edinburgh  $50,000  on each of September 30, 2003, October 31, 2003 and
November  28,  2003  ($150,000  paid);

ii)  pay Edinburgh the accrued interest for September 30, 2003 onward on January
5,  2004,  April  5,  2004,  July  15,  2004  and  October  5,  2004;

iii)  pay  Edinburgh  15%  of  all  funds  received  from  the Bridgeport School
contract until the principal and interest is fully paid;  deliver to Edinburgh a
five  year  warrant  to purchase 13,440,000 common stock at an exercise price of
$0.15  per  share
                                                                                  $   1,680,000
                                                                                  =============
</TABLE>


                                       17
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  9     STOCK  WARRANTS  AND  OPTIONS

1.     The  company  has  the  following  warrants  outstanding:

<TABLE>
<CAPTION>
              NUMBER       PRICE         EXPIRATION
            OF SHARES    PER SHARE          DATE
            ----------  ------------  -----------------
<S>        <C>          <C>           <C>
            1,810,000   $     0.15    February 17, 2004
               20,000   $     0.15    February 27, 2004
            7,083,333*  $     0.15    June 13, 2005
           12,019,880   $     0.15    September 18, 2005
</TABLE>

*     The Company has the right to force the conversion of these warrants if the
stock  price  of the Company's common stock exceeds $1.20 per share for a ninety
day  period.

2.     The  Company has agreed to issue additional warrants in consideration for
extension  agreements on notes payable for 16,000,000 shares at $0.125 per share
for  a  period  of  two  years  (see  Note  7)

3.     During the period, the Company settled $100,000 of convertible debentures
by issuing 1,100,000 shares and agreed to issue 1,100,000 warrants entitling the
holder  thereof  the right to purchase one common share for each warrant held at
$0.15  per  share  for  a  period  of  two  years.

4.     Pursuant  to  a  court order, the Company is required to issue 13,440,000
warrants  as  part of a settlement of it's convertible debentures.  Each warrant
entitles  the  holder thereof the right to acquire one common share at $0.15 per
share  for  a  period  of  five  years  (see  Note  8).

5.     Stock-based  Compensation  Plan

On  April  29, 2002, the Company adopted the 2002 employee stock option plan for
the  purpose  of  providing  an  incentive  based  form  of  compensation to the
officers,  directors, key employees and service providers of the Company.  These
options  were  granted  with  an exercise price equal to the market price of the
Company's  stock  on  the  date  of  the  grant.

<TABLE>
<CAPTION>
                                                      September 30, 2003
                                                  --------------------------
                                                                Weighted
                                                  Optioned       Average
                                                   Shares    Exercise Price
                                                  ---------  ---------------
<S>                                               <C>        <C>
Outstanding, beginning of the year . . . . . . .  4,234,091  $          0.11
Granted. . . . . . . . . . . . . . . . . . . . .  4,050,000             0.12
                                                  ---------  ---------------

Outstanding and exercisable at end of the period  8,284,091  $          0.11
                                                  =========  ===============
</TABLE>


                                       18
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  9     STOCK  WARRANTS  AND  OPTIONS  (CONTINUED)

At  September  30, 2003 the following consultant or employee and director common
share  purchase  options  were outstanding and exercisable entitling the holders
thereof  the  right  to purchase one common share for each share purchase option
held:

<TABLE>
<CAPTION>
              NUMBER       PRICE         EXPIRATION
            OF SHARES    PER SHARE          DATE
            ----------  ------------  -----------------
<S>        <C>          <C>           <C>
            2,859,091   $     0.11    April 28, 2004
            1,000,000   $     0.11    April 30, 2004
              100,000   $     0.20    June 20, 2004
               50,000   $     0.17    October 7, 2004
              100,000   $     0.14    October 14, 2004
            4,000,000   $     0.11    July 6, 2005
               50,000   $     0.11    August 31, 2005
              125,000   $     0.11    June 27, 2012
            ----------
            8,284,091
            ==========
</TABLE>

The  Company accounts for its stock-based compensation using the intrinsic value
method in accordance with Accounting Principles Board Opinion No. 25 "Accounting
for  Stock  Issued  to  Employees"  and  its  related  interpretations.

Under  SFAS  No. 123, if the Company elects to follow APBO No. 25, in respect to
the  employees stock options, it is required to present pro-forma information as
to  the  effect on income and earnings per share as if the Company had accounted
for  its  employee  stock options under the fair value method of that statement.
Had compensation cost been determined based on the fair value at the grant dates
for those options issued to officers, directors and employees, the Company's net
loss  and  loss  per  share  would  have  been adjusted to the pro-forma amounts
indicated  below:

<TABLE>
<CAPTION>
                                        September 30,
                                      2003        2002
                                   ----------  ----------
<S>                                <C>         <C>
Net loss. . . . . . . . . . . . .  $(321,077)  $(185,802)
Pro-forma adjustment for SFAS 123   (283,500)          -
                                   ----------  ----------

Pro-forma net loss. . . . . . . .  $(604,577)  $(185,802)
                                   ==========  ==========

Pro-forma net loss per share. . .  $   (0.01)  $   (0.00)
                                   ==========  ==========
</TABLE>


                                       19
<PAGE>

SECURITY  BIOMETRICS,  INC.
CONSOLIDATED  FINANCIAL  STATEMENTS
NOTES  TO  UNAUDITED  CONSOLIDATED  FINANCIAL  STATEMENTS

NOTE  9     STOCK  WARRANTS  AND  OPTIONS  (CONTINUED)

The fair value of these options was estimated at the date of the grant using the
following  weighted  average  assumption:

                                                                          2003
                                                                        --------
Volatility  factor  of  expected  market  price  of  company's  shares     199%
Dividend  yield                                                              0%
Weighted  average  expected  life  of  stock  options                   2  years
Risk-free  interest  rate                                                    5%

The Black-Scholes option valuation model was developed for use in estimating the
fair  value  of  traded options which have no vesting restrictions and are fully
transferable.  In  addition, option valuation models require the input of highly
subjective  assumptions,  including  expected  share  price  volatility.  The
Company's  employee  stock  options have characteristics significantly different
from  those  of  traded options, and changes in the subjective input assumptions
can  materially  affect  fair  value  estimates.

NOTE  10     BUSINESS  SEGMENTS

SFAS  No.  131,  "Disclosure  about  Segments  of  an  Enterprise  and  Related
Information",  requires  companies  to  provide  certain information about their
operating  segments.  The  Company  has  three  reportable  segments:  Security
Biometrics,  Lightec,  and  eMedRx.

Summarized  financial  information, concerning the Company's reportable segments
for  three  months  ended  September  30, 2003, is shown on the following table:

<TABLE>
<CAPTION>
                                    SECURITY
                                   BIOMETRICS   LIGHTEC    EMEDRX      TOTAL
                                  ------------  --------  ---------  ----------
<S>                               <C>           <C>       <C>        <C>
Net sales to external companies.  $    12,067   $158,700  $      -   $ 170,767
Operating earnings (loss). . . .     (736,133)    77,794   (22,671)   (681,010)
Total assets . . . . . . . . . .      308,730    161,417     4,683     474,830
Depreciation and amortization. .        2,275        212         -       2,487
Capital expenditures . . . . . .        2,087          -         -       2,087
</TABLE>


                                       20
<PAGE>

ITEM  2.     MANAGEMENT'S  DISCUSSION  AND  ANALYSIS  OR  PLAN  OF  OPERATIONS

When  used  in  this Form 10-QSB, the words "anticipated", "estimate", "expect",
and  similar  expressions  are  intended to identify forward-looking statements.
Such  statements  are  subject  to  certain risks, uncertainties and assumptions
including the possibility that we will fail to generate planned revenues. Should
one  or  more  of these risks or uncertainties materialize, or should underlying
assumptions  prove  incorrect,  actual  results  may  vary materially from those
anticipated,  estimated  or  projected.

The  following  discussion  and  analysis of financial conditions and results of
operation  should  be  read  in  conjunction  with  our  consolidated  financial
statements and notes thereto included elsewhere in this Form 10-QSB and year end
10-KSB  filing.

Critical  Accounting  Policies
==============================

Our discussion and analysis of our financial condition and results of operations
are  based  upon  our  consolidated  statements,  which  have  been  prepared in
accordance  with  accounting principles generally accepted in the United States.
The  preparation of these financial statements requires us to make estimates and
judgments  that affect the reported amounts of assets, liabilities, revenues and
expenses.  In  consultation  with our Board of Directors and Audit Committee, we
have  identified  two  accounting  policies  that  we  believe  are  key  to  an
understanding  of  our  financial  statements.  These  are  important accounting
policies  that  require  management's  most  difficult,  subjective  judgments.

The  first  critical  accounting  policy  relates  to  revenue  recognition.  We
recognize  revenue  from  fixed  price  and  modified  fixed  price construction
contracts  on the percentage-of-completion method, measured by the percentage of
cost  for each contract.  This method is used because management considers total
cost  to  be  the  best available measure of progress on the contracts.  License
revenues  are recognized when earned, in accordance with contractual provisions.
Royalty  revenues  are  recognized  upon  shipment of products incorporating the
related technology by the original equipment manufacturers (OEMs) and foundries.

The  second  critical  accounting  policy  relates  to  intangible  assets.  Our
intangible  assets  consist  primarily of goodwill. In accordance with SFAS 142,
"Goodwill  and  Other  Intangible  Assets," only intangible assets with definite
lives  are  amortized.  Non-amortized  intangible  assets are instead subject to
annual  impairment  testing.

Principles  of  consolidation; the consolidated financial statements include the
accounts  of  Security  Biometrics,  Inc.  and  the  following  subsidiaries:
Biometrics  Security,  Inc.
Netface,  LLC  (Inactive)
Lightec  Communications  Corp.
Datadesk  Technologies,  Inc.  (Disposed  on  August  20,  2003)
eMedRx,  Inc.

All  material  inter-company  accounts  and  transactions  have been eliminated.
Depreciation;  the  Company depreciates its property and equipment for financial
reporting  purposes  using  the  straight-line  method  based upon the following
useful  lives  of  the  assets:

                         Furniture  and  fixtures       7-10  years
                         Machinery  and  equipment         5  Years
                         Computer  equipment               5  Years
                         Vehicles                          5  Years

Foreign  Currency;  the  consolidated  financial  statements  of the Company are
measured  using  the  United  States  dollar  as  the  functional  and reporting
currency.  Assets, liabilities and equity accounts of the Company are translated
from  foreign  currency  to  United  States currency at exchange rates as of the
balance  sheet  date  or historical acquisition date, depending on the nature of
the  account.  Revenues and expenses are translated at average rates of exchange
in  effect  during  the  year.  The resulting cumulative translation adjustments
have  been  recorded  as  a  separate  component  of  stockholders'  equity.


                                       21
<PAGE>

Income Tax; provisions for income taxes are based on taxes payable or refundable
for  the  current  year  and deferred taxes on temporary differences between the
amount  of  taxable income and pretax financial income and between the tax basis
of  assets  and  liabilities  and  their  reported  amounts  in  the  financial
statements.  Deferred  tax  assets and liabilities are included in the financial
statements  at  currently  enacted  income tax rates applicable to the period in
which  the  deferred  tax  assets and liabilities are expected to be realized or
settled  as  prescribed  in FASB Statement No. 109, Accounting for Income Taxes.
As changes in tax laws or rates are enacted, deferred tax assets and liabilities
are  adjusted  through  the  provision  for  income  taxes.

Account  estimates;  management  uses  estimates  and  assumptions  in preparing
financial  statements  in  accordance  with  generally  accepted  accounting
principles.  Those  estimates  and  assumptions  affect  the reported amounts of
assets and liabilities, the disclosure of contingent assets and liabilities, and
the  reported  revenues  and  expenses.  Actual  results  could  vary  from  the
estimates  that  were  used.

HISTORY
=======

Security  Biometrics, Inc. was incorporated as Great Bear Resources, Inc. in the
State  of  Nevada  on  March  12,  1999  and  we  changed our name to Great Bear
Investments,  Inc.  on  May 25, 1999. On August 11, 2000, we changed our name to
Security  Biometrics,  Inc.  We were a development stage company whose objective
was to develop market under license and istribute dynamic biometric technologies
specific  to  the  security  applications of banking and financial transactions,
including dynamic gesture recognition technology, dynamic signature verification
and  voice  recognition.

On  August  22,  2000,  we entered into an option agreement with DSI Datotech of
Vancouver,  Canada. The exercise price of the option was $8,000,000, of which we
paid  $320,000.  On June 29, 2001, we acquired all of the outstanding membership
interests  of NetFace, LLC, a Connecticut limited liability company, in exchange
for  20,000,000 share of our common stock. NetFace holds an option to acquire an
exclusive  worldwide,  perpetual,  royalty-free license to exploit DSI's gesture
recognition  technology  for  video  games and Internet/television. The exercise
price  of  the  option  is  $5,000,000 plus a 20% Class B Membership of NetFace.

On  April  20,  2002, the Company entered into an exclusive rights and licensing
distribution  and  partnership  agreement  with  WonderNet  Ltd.  of  Israel.

Under this agreement, we became the exclusive distributor for North America, the
Caribbean  and  Mexico  of  WonderNet's  Penflow(TM)  patented  and  proprietary
Biometric  Signature Authentication ("BSA") software engine, which consists of a
database  of  user  profiles  and enable remote and local access to the database
using  the  internet,  smart  cards,  or LAN connections to verify signatures by
comparison  to  said  database.  To  acquire  these  rights, we issued WonderNet
2,500,000  shares  of  common  stock  and  agreed  to pay WonderNet a 5 per cent
royalty  on  products  sold. Penflow's commercial performance led to write downs
associated  with  WonderNet  however, our confidence in the commercial prospects
for  this product going forward led us to renew the agreement in August 2003. We
anticipate  significantly  improved  commercial  performance  in  response  to
increased investment in sales and marketing of the product supported by revenues
from  Lightec  and  sales  of  securities.

The  agreement  with  WonderNet allows us to commence sub-licensing, marketing a
proven  biometric  security  product.  We  have  decided  to not to exercise our
options  with DSI Datotech at this time as we do not believe that the prototypes
delivered  to  us  are  market  ready  at  this  time. Consequently, the Company
expensed $320,000 in 2001 and the balance of the investment of $200,000 in 2002.

A  revised agreement with Wondernet was agreed in September 2003. This agreement
includes a minimum payment of $120,000 per quarter against license fees. Because
this  minimum  payment  was not exceeded in license fee accruals this amount was
expensed.


                                       22
<PAGE>

Management  Team
================

There  were  substantial  changes  to  the  executive management team during the
quarter. Michel Berty was appointed as CEO shortly before year end following the
death  of  the  previous  CEO,  Mr Kenneth Barr. Mr Berty subsequently appointed
William  Moore  as  CFO  (Sept  1st  2003), Jeff Maynard as President and CEO of
EmedRX (September 8th 2003) and Herve Bertacchi as vice president and manager of
the  Lightec Communications business (August 18, 2003). The executive management
of  the  business  was  also  relocated  from Vancouver, Canada to New York City
reflecting  the  business's  increased  focus  on  the  larger  US  market.

Revised  Sales  Strategy
========================

The  executive  management  team  has also refocused sales on direct channels to
clients  rather than using alternate channels like Value Added Resellers (VARS).
This  has resulted in the hiring of additional resources for the sales force and
reflects  a  desire  to maintain superior margins and 'customer ownership.' SBTI
will  continue  to  use  in-direct  channels  where  appropriate  but  only as a
supplement  to  direct  channels.

We  believe  that the sales cycle for the Penflow product is relatively long due
to  the  potential impact on client's business processes where it is implemented
on  a  large  scale. Management believes that the length of sales cycle for this
product  means  that  increased investment in sales and marketing is unlikely to
have  a  significant  impact  on revenue performance until the later half of our
financial  year.

EmedRX
======

The  first  quarter  saw  the launch of EmedRX as a healthcare specific vertical
application  incorporating Penflow technology, following the appointment of Jeff
Maynard. The management team anticipates that this will be the first in a series
of  vertical specific offerings from SBTI featuring signature authentication and
biometric  technology as a differentiator. Management believes that the progress
made  in  identifying  pilot  partners  is  significant  and  that this supports
forecasting  of  contract  closure  in  subsequent  quarters. EmedRX is pursuing
commercial  opportunities  in USA and Canada and has therefore been divided into
two  separate  corporate  entities  to  focus  on each of the territories and to
provide  opportunities  for  other  investors to participate in ownership of the
business.

Lightec
=======

The Lightec Communications business also saw significantly increased activity as
client  accounts became more active. Lightec recognized $158,700 of revenue this
quarter.  The  management  also  saw  additional  funds  being  released for its
Bridgeport  Schools  contracts  and  believes  that  there are strong grounds to
expect  significantly  increased  revenues  which  we  believe  will fulfill the
remaining  approximately  $6.7mm  dollars  of  the  contract over the next three
quarters to reach the anticipated contract value of $6.9 million dollars for the
year.

Penflow
=======

Additional  resources  have  been  applied  to  sales  and  marketing of Penflow
products.  The  management believes that the sales cycle for Penflow products is
lengthy and therefore does not expect to see significant revenue generation from
these  products  reflected  in financial statements until the second half of the
company's  financial  year.


                                       23
<PAGE>

Datdesk
=======

The  divestment of Datadesk was completed in August 2003 as previously described
in  our  10-KSB  filing.  The  Datadesk  operation had produced some of the core
elements  of the EmedRX application and it was decided to focus the resources of
SBTI  on  its  core Penflow technology and the further development of the EmedRX
application  and  commercial  opportunities  in  the  healthcare  sector.

In  order  to  execute the divestiture it was mutually agreed by SBTI and Robert
Solomon,  (President  of  Datadesk  and  CTO  of  SBTI)  to  cancel Mr Solomon's
employment  agreement  with SBI and transfer ownership of Datadesk to PanPacific
for  a  consideration  of  $1,000,000.  The  effective date of the agreement and
transfer  of  ownership  was August 20th, 2003 and is reflected in a significant
reduction  in  goodwill  in  our  financial  statements.

The  Company  realized  a  net  gain  on  the disposal of Datadesk subsidiary of
$382,073  which was recognized at the date of disposition.  The realized gain is
net  of  approximately  $47,949  transaction  costs.

REVENUES
========

Contract  revenues  fell  from  $667,534 in Q1 2002 to $158,700 in Q1 2003. This
reflects  accounting  policies  relating  to  revenue recognition in the Lightec
business.  Contracts  with  the  Bridgeport  schools  district and other clients
became  considerably  more  active  during  the  Q1  2003 period as reflected in
invoices  dispatched  by  SBTI  as  a  hardware  reseller  and  we  expect these
activities  to  be  reflected  in  subsequent  periods'  revenue  figures.

Other  revenues  grew  from $10,000 in Q1 2002 to $12,607 in Q1 2003. Management
believes  that  these  revenues  reflect  a relatively long sales cycle as noted
herein.  Management  does  not  believe  that  increased investment in sales and
marketing  will be reflected in revenue significantly improved performance until
the  third  or  fourth  quarters  of  our  financial  year.

Current  Liabilities/  Accounts  Payable
========================================

Amounts  due to related parties remained virtually the same from the year end to
September  30,  2003.  Accounts  payable  and  accrued  liabilities increased by
$287,848  during  the  quarter.

Notes  Payable
==============

Notes  in  the  amount  of $1,000,000 to facilitate the purchase of Lightec were
payable to Maryanne Richard and Synergex Group Partnership. Each note bearing an
interest  rate  of  9%.  The  notes  have  subsequently  been  adjusted.

Maryanne  Richard;  pursuant to an agreement dated October 29, 2003, the Company
has  agreed  to  set  the principal of the note at $1,105,000 ("new principal").
Interest will accrue on the new principal at the rate of 9% per annum commencing
on  the  date of the first receipt of funds from the Bridgeport School contract.
Payments  against  the new principal and accrued interest will commence once the
$281,500 included in accounts payable - related entities, has been repaid.  This
$281,500  is  owed to Mike Richard (a former director of Lightec) pursuant to an
employment  contract.  9%  of  the  receipts from the Bridgeport School contract
will  be  applied  against  these  debts.

Synergex Partnership; in addition to the principle an accrued interest liability
of  $117,370  is  also  recorded  at  September  30,  2003.

The  payment  terms  and  certain  security rights are recorded in Note 7 to the
financial  statements,  attached.


                                       24
<PAGE>

Liquidity  and  Capital  Resources
==================================

At  September  30  2003  we  believe  that  the  positive  cashflow from Lightec
Communications  could  have a significant role in funding the SBTI business as a
whole  for  the  remainder of the year. However, due to debt service obligations
and  the  management's strategy to invest in activities and operations that will
we  believe will provide significant long term gains but will not necessarily be
cashflow  positive  in  the very short term we continue to forecast the need for
additional  financing  from  sales  of  stock  and other sources. Should this be
unattainable  it  would  have  a significant impact on the business's ability to
operate.


ITEM  3     CONTROLS  AND  PROCEDURES.

An evaluation was performed, as of September 30, 2003, under the supervision and
with the participation of our management, including our Chief Financial Officer,
of  the effectiveness of the design and operation of our disclosure controls and
procedures.  Based  on  such  evaluation,  our management has concluded that our
disclosure  controls  and  procedures  were  effective as of September 30, 2003.
There have been no significant changes in our internal controls or other factors
that  could  significantly  affect our internal controls subsequent to September
30,  2003.

PART  II     OTHER  INFORMATION

Item  1.     Legal  Proceedings.

A  SETTLEMENT  WAS  REACHED  WITH  EDINBURGH INVESTMENTS LLC ON AUGUST 29TH 2003
COVERED  BY  A STIPULATION FOR JUDGMENT BY A NEVADA DISTRICT COURT. THE TERMS OF
THE  SETTLEMENT  INCLUDED  A LIEN AGAINST CERTAIN FUTURE REVENUES RESULTING FROM
CERTAIN  EDUCATION  CONTRACTS  HELD  BY  SBTI,  LIGHTEC  AND  OR  OTHER  SBTI
SUBSIDIARIES.

Neither  we,  nor  any  of  our  subsidiaries,  is  a  party  to  any  material
legal  proceeding,  nor, to our knowledge, is any material litigation threatened
against  us  or  our  subsidiaries.

Item  2.     Changes  in  Securities

During  the  first  quarter, we issued 10,263,750 shares of our common stock for
cash  proceeds  of  $819,749  from the private placements. In addition 1,100,000
shares  were  issued  to  Librcor  pursuant  to  a  conversion  of a convertible
debenture for $100,000, and 500,000 shares were issued to Thien Pham pursuant to
an  agreement  to purchase the intellectual property rights, and source codes to
Digital  RX  and  eMedRx.  We  believe  that the issuance of such shares did not
require  registration  under the Securities Act of 1933, as amended, pursuant to
exemptions  available  under  the  provisions  of  Sections  4(2)and 4(6) of the
Securities  Act.

Item  3     Defaults  on  Senior  Securities.

SEE  ITEM  1.

Item  4.     Submission  of  Matters  to  a  Vote  of  Security  Holders.

None

Item  5.     Other  Information  -  None

Item  6.     Exhibits  and  Reports  on  Form  8-K

(a)     Exhibits.

Set  forth  below  is  a  list  of the exhibits to this Quarterly Report on Form
10-QSB


                                       25
<PAGE>

Exhibit  Description
Number

99.1     Certificate  of  Michel  Berty  pursuant  to  18 U.S.C.1350, as adopted
         pursuant  to  section  906  of  the  Sarbanes-Oxley  Act  of  2002.

99.2     Certificate  of  William  Moore  pursuant  to 18 U.S.C.1350, as adopted
         pursuant  to  section  906  of  the  Sarbanes-Oxley  Act  of  2002.


(b)     Reports  on  Form  8-K

None

                                   SIGNATURES


In  accordance  with  Section  13  or 15 (d) of the Exchange Act, the registrant
caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.

                                By:  /s/  Michel  Berty
                                -----------------------
                                Name:  Michel  Berty
Date:  December  9,  2003       Title:  Chairman  and  Chief  Executive  Officer


                                By:  /s/  William  Moore
                                ------------------------
                                Name:  William  Moore
Date:  December  9,  2003       Title:  Chief  Financial  Officer


                             CERTIFICATE PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                               SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

In  connection  with  the  Quarterly  Report  of Security Biometrics, Inc., (the
"Company")  on  Form  10-QSB  for the nine month period ended March 31, 2003, as
filed  with  the  Securities  and  Exchange  Commission  on the date hereof (the
"Report"), we certify pursuant to 18 U.S.C. (S) 1350, as adopted pursuant to (S)
906  of  the  Sarbanes-Oxley  Act  of  2002,  that:

     1.  The Report fully complies with the requirements of Section 13 (a) or 15
(d)  of  the  Securities  Exchange  Act  of  1934;  and

     2. The information contained in the Report fairly presents, in all material
respects,  the  financial  condition  and  results  of operation of the Company.


Date:  December  9,  2003            By:  /s/  Michel  Berty
                                     -----------------------
                                     Name: Michel Berty, Chief Executive Officer


                                       26
<PAGE>

                             CERTIFICATE PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                               SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

In  connection  with  the  Quarterly  Report  of Security Biometrics, Inc., (the
"Company")  on  Form 10-QSB for the three month period ended September 30, 2003,
as  filed  with  the  Securities and Exchange Commission on the date hereof (the
"Report"), we certify pursuant to 18 U.S.C. (S) 1350, as adopted pursuant to (S)
906  of  the  Sarbanes-Oxley  Act  of  2002,  that:

     1.  The Report fully complies with the requirements of Section 13 (a) or 15
(d)  of  the  Securities  Exchange  Act  of  1934;  and

     2  The information contained in the Report fairly presents, in all material
respects,  the  financial  condition  and  results  of operation of the Company.



Date:  December  9,  2003           /s/  William  Moore
                                    -------------------
                                    Name: William Moore, Chief Financial Officer


                                       27
<PAGE>